India Non-invasive Prenatal Testing Market Share, Insights, Forecast & Trends 2025-2033

According to IMARC Group’s report titled "India Non-Invasive Prenatal Testing Market Size, Share, Trends and Forecast by Gestation Period, Risk, Method, Technology, Product, Application, End Use, and Region, 2025-2033" the report offers a comprehensive analysis of the industry, including India non-invasive prenatal testing market share, growth, trends, and regional insights.

Update Note : We are in the process of updating our reports to cover the 2026–2034 forecast period. For the most recent data, insights, and industry updates, please click on ‘Request Free Sample Report.

Request Free Sample Report : https://www.imarcgroup.com/india-non-invasive-prenatal-testing-market/requestsample

India Non-invasive Prenatal Testing Market Overview

The India non-invasive prenatal testing market size reached USD 0.40 Billion in 2024. The market is expected to grow at a CAGR of 11.50% during the forecast period from 2025 to 2033, reaching a value of USD 1.20 Billion by 2033. This growth is driven by factors such as rising maternal age, increasing awareness about genetic disorders, advancements in prenatal screening technology, and expanding healthcare infrastructure.

India Non-invasive Prenatal Testing Market Study Assumption Years

• Base Year : 2024
• Historical Year/Period : 2019-2024

India Non-invasive Prenatal Testing Market Key Takeaways

• Current Market Size : USD 0.40 Billion
• CAGR : 11.50%
• Forecast Period : 2025-2033
• The market growth is propelled by rising maternal age and increasing awareness about genetic disorders.
• Advancements in prenatal screening technologies such as next-generation sequencing and cell-free fetal DNA analysis are improving test accuracy and accessibility.
• Growing healthcare infrastructure and expanding diagnostic services in metro and tier-2 cities support market expansion.
• Increasing disposable incomes and government initiatives like Ayushman Bharat promote the adoption of non-invasive prenatal testing.
• Research efforts and insurance coverage improvements contribute to wider use of NIPT as a standard prenatal care procedure.

visit the India Non-invasive Prenatal Testing Market: https://www.imarcgroup.com/india-non-invasive-prenatal-testing-market

India Non-invasive Prenatal Testing Market Growth Factors

The India non-invasive prenatal testing market is primarily driven by rising maternal age and increasing awareness about genetic disorders. These factors have heightened the demand for safer and more effective prenatal diagnostic methods. Non-invasive prenatal testing (NIPT) provides a high sensitivity and early detection advantage over invasive methods, reducing risk of miscarriage and offering expectant mothers a safer option. The growing preference for safer diagnostics among expectant mothers supports the sustained market growth.

Advancements in prenatal screening technology are significantly fueling the market expansion. Innovations in next-generation sequencing (NGS), cell-free fetal DNA analysis, and AI-based genetic screening have enhanced the accuracy, efficiency, and accessibility of NIPT. These technological improvements have made prenatal testing more affordable and accessible in urban and semi-urban regions, creating a favorable market outlook.

Increasing disposable incomes among middle-class families and supportive government initiatives are important growth enablers. Rising per capita disposable income encourages preventive healthcare investments, including advanced prenatal screening. Government programs such as Ayushman Bharat elevate awareness of maternal and fetal health, promoting genetic testing adoption. Public-private partnerships and insurance coverage expansion further increase the accessibility and affordability of NIPT services across India.

India Non-invasive Prenatal Testing Market Trends

Technological innovations in prenatal screening have transformed the India non-invasive prenatal testing market. The prominence of next-generation sequencing (NGS), cell-free fetal DNA analysis, and AI-driven genetic screening tools have greatly improved the diagnostic accuracy, efficiency, and reach of NIPT. Compared to traditional invasive procedures like amniocentesis and chorionic villus sampling (CVS), NIPT offers early detection with zero risk of miscarriage.

The continuous research and development have expanded NIPT panels to cover a broader range of conditions, including microdeletions, single-gene disorders, and fetal sex determination where legally allowed. These expanded panels enhance the clinical scope and utility of NIPT in India.

Cost reductions in genetic sequencing technologies have also increased the affordability and penetration of NIPT in both urban and semi-urban areas. Notable advancements include the launch of innovative prenatal screening technologies such as CNSeq and MaatriSeq by Strand Life Sciences in 2024, tailored to the Indian community's unique genetic landscape, providing superior efficiency and precision.

Improvements in healthcare infrastructure, with the establishment of specialized maternal-fetal medicine centers, genetic counseling services, and private diagnostic labs across metro and tier-2 cities, have increased the accessibility of NIPT services. Leading diagnostic providers including MedGenome, Lilac Insights, and Apollo Diagnostics are expanding their offerings, facilitating market growth.

The growing adoption of NIPT is supported further by insurance providers gradually covering genetic tests, positioning these diagnostics as a standard element of prenatal care. Government initiatives promoting maternal and fetal health under programs such as Ayushman Bharat are raising awareness and driving public-private collaborations to make affordable prenatal screening widely accessible, especially in underserved regions.

Buy the Full Report for Complete Data, Trends, and Opportunities: https://www.imarcgroup.com/checkout?id=30833&method=1337

India Non-invasive Prenatal Testing Market Segmentation

Gestation Period Insights:

• 0-12 Weeks
• 13-24 Weeks
• 25-36 Weeks

The market is segmented based on gestation periods, providing detailed analysis for testing performed during 0-12 weeks, 13-24 weeks, and 25-36 weeks of pregnancy.

Risk Insights:

• High and Average Risk
• Low Risk

This segmentation categorizes the market based on pregnancy risk levels, distinguishing between high and average risk groups and low risk groups.

Method Insights:

• Ultrasound Detection
• Biochemical Screening Tests
• Cell-Free DNA In Maternal Plasma Tests

The methods segment includes ultrasound detection, biochemical screening tests, and cell-free DNA analysis in maternal plasma.

Technology Insights:

• NGS
• Array Technology
• PCR
• Others

The technologies involved encompass next-generation sequencing (NGS), array technology, PCR, and other methods used in non-invasive prenatal testing.

Product Insights:

• Consumables and Reagents
• Instruments

The product segment covers consumables and reagents as well as instruments used in NIPT procedures.

Application Insights:

• Trisomy
• Microdeletion Syndrome
• Others

Applications covered include detection of trisomy, microdeletion syndromes, and other genetic abnormalities.

End Use Insights:

• Hospitals and Clinics
• Diagnostic Laboratories

The market is analyzed based on end users, specifically hospitals and clinics, and diagnostic laboratories.

India Non-invasive Prenatal Testing Market Regional Insights

• North India
• South India
• East India
• West India

The North India region dominates the market with the largest share. The overall India non-invasive prenatal testing market is expected to grow at a CAGR of 11.50% during 2025-2033, with significant contributions from all major regions.

India Non-invasive Prenatal Testing Market Key Players

The report offers an in-depth examination of the competitive landscape, including market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.

India Non-invasive Prenatal Testing Market Recent Developments & News

In May 2024, Metropolis Healthcare Limited, a leading diagnostic service provider in India, published results from a comprehensive three-year study (January 2021 to December 2023) involving 140,528 expectant mothers. The study highlighted the critical effectiveness of Pregascreen Reflex Testing combined with Non-invasive Prenatal Testing (NIPT) or Karyotyping in accurately identifying high-risk pregnancies. This advancement represents a significant step in prenatal care, emphasizing Metropolis' commitment to raising awareness and improving health outcomes for women and children in India.

India Non-invasive Prenatal Testing Market Key Highlights of the Report

• Comprehensive quantitative analysis of market segments from 2019 to 2033.
• Insights into industry catalysts, challenges, and future market outlook.
• Detailed segmentation analysis covering gestation period, risk, method, technology, product, application, end use, and region.
• Porter’s five forces analysis for assessing market competitiveness.
• Competitive landscape and company evaluation quadrant.
• Profiles of major market players.

Get Your Customized Market Report Instantly: https://www.imarcgroup.com/request?type=report&id=30833&flag=E

Customization Note: If you require any specific information not covered within this report’s scope, we will provide it as part of the customization.

About Us

IMARC Group is a global management consulting firm that helps ambitious changemakers create a lasting impact. The company offers comprehensive market assessment, feasibility studies, incorporation support, regulatory assistance, branding and strategy services, and procurement research.

Contact Us

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel: (D) +91 120 433 0800

United States: +1-201971-6302